Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference22 articles.
1. World Health Organization. Pneumococcal Conjugate Vaccines in Infants and Children Under 5 Years of Age: WHO Position Paper - February 2019, https://apps.who.int/iris/bitstream/handle/10665/310968/WER9408.pdf?ua=1; 2019 [accessed September 23, 2020].
2. Wahl B, O'Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type B disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health 2018;6:e744–e757. https://dx.doi.org/10.1016/S2214-109X(18)30247-X.
3. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6–18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2013
4. Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL, et al. Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs. Clin Infect Dis 2016;62:139–147. https://dx.doi.org/10.1093/cid/civ803.
5. Hofstetter AM, LaRussa P, Rosenthal SL. Vaccination of adolescents with chronic medical conditions: special considerations and strategies for enhancing uptake. Hum Vaccin Immunother 2015;11:2571–2581. https://dx.doi.org/10.1080/21645515.2015.1067350.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献